By highlighting both mechanistic insights and translational advances, the review article outlines how next-generation engineered peptide therapeutics, used alone or in combination with existing disease-modifying agents, may help reshape the future landscape of AD diagnosis, prevention, and treatment
Collectively, these steps aim to build an integrated framework linking mechanistic understanding, targeted delivery technologies, and clinical validation, advancing ferroptosis-based therapy from FRDA research toward precision treatment
Comprehensive baseline cancer screening appropriate for age and risk (PSA, colonoscopy, mammography, skin exam)
Environmental pollutants, sun exposure, poor diet, chronic stress, smoking, and lack of sleep all contribute to oxidative stress, speeding up skin damage and aging
A MTHFR mutation can be heterozygous (1 abnormal gene) or homozygous (2 abnormal genes)